TALEN-based gene correction

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9393257
APP PUB NO 20140256798A1
SERIAL NO

14193037

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention is directed to transcription activator-like effector nuclease (TALEN)-mediated DNA editing of disease-causing mutations in the context of the human genome and human cells to treat patients with compromised genetic disorders.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • REGENTS OF THE UNIVERSITY OF MINNESOTA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Blazar, Bruce Golden Valley, US 17 158
Osborn, Mark J St. Paul, US 3 39
Tolar, Jakub Minneapolis, US 15 157
Voytas, Daniel F Falcon Heights, US 48 1334

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 19, 2024
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 19, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00